(PharmaNewsWire.Com, January 09, 2018 ) In this region, North America IUCD Devices Market is projected to reach USD 1,441.0 million by 2024, from USD 872.3 million in 2016 growing at a CAGR of 6.6% in the forecast period 2017 to 2024.
Based on geography, the North America IUCD devices market is segmented into 3 geographical regions, such as, U.S., U.K, Mexico, Canada
North America IUCD devices market competition by top players including - Bayer AG dominated the IUCD devices market, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Also Medigen Distribution, Inc. and Allergen PLC are expected to hold respectively. Some of the other players in this market include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA SMB Corporation Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind and Com Ltda, Bersil, Amed
About Us: Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical. Contact: Dani Rodriguez Partner Relation Executive Research Cosmos Direct Line: +1 888 709 8757 Mail: dani@researchcosmos.com www.researchcosmos.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
